NEUROCRINE BIOSCIENCES INC (NBIX)
US64125C1099 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 163.72. This target is 12.08% above the current price.
NBIX was analyzed by 34 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-25 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-25 | Needham | Reiterate | Hold |
| 2024-07-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-07-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-06-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-05-29 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-28 | UBS | Maintains | Buy -> Buy |
| 2024-05-14 | Evercore ISI Group | Initiate | Outperform |
| 2024-05-03 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-05-02 | Guggenheim | Maintains | Buy -> Buy |
| 2024-05-02 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-05-02 | Needham | Reiterate | Hold |
| 2024-05-02 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-02 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-02 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-01 | Needham | Reiterate | Hold |
| 2024-04-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-24 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-04-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-23 | Needham | Reiterate | Hold |
| 2024-04-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-08 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-02-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-01-25 | Goldman Sachs | Maintains | Buy -> Buy |